Microspectrofluorimetry to dissect the permeation of ceftazidime in Gram-negative bacteria

Abstract A main challenge in chemotherapy is to determine the in cellulo parameters modulating the drug concentration required for therapeutic action. It is absolutely urgent to understand membrane permeation and intracellular concentration of antibiotics in clinical isolates: passing the membrane b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anas Allam, Laure Maigre, Julia Vergalli, Estelle Dumont, Bertrand Cinquin, Rodolphe Alves de Sousa, Jelena Pajovic, Elizabeth Pinet, Nikaia Smith, Jean-Philippe Herbeuval, Matthieu Réfrégiers, Isabelle Artaud, Jean-Marie Pagès
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ca80691df79d435fac589a85f21b0920
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ca80691df79d435fac589a85f21b0920
record_format dspace
spelling oai:doaj.org-article:ca80691df79d435fac589a85f21b09202021-12-02T16:08:12ZMicrospectrofluorimetry to dissect the permeation of ceftazidime in Gram-negative bacteria10.1038/s41598-017-00945-82045-2322https://doaj.org/article/ca80691df79d435fac589a85f21b09202017-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-00945-8https://doaj.org/toc/2045-2322Abstract A main challenge in chemotherapy is to determine the in cellulo parameters modulating the drug concentration required for therapeutic action. It is absolutely urgent to understand membrane permeation and intracellular concentration of antibiotics in clinical isolates: passing the membrane barrier to reach the threshold concentration inside the bacterial periplasm or cytoplasm is the pivotal step of antibacterial activity. Ceftazidime (CAZ) is a key molecule of the combination therapy for treating resistant bacteria. We designed and synthesized different fluorescent CAZ derivatives (CAZ*, CAZ**) to dissect the early step of translocation-accumulation across bacterial membrane. Their activities were determined on E. coli strains and on selected clinical isolates overexpressing ß-lactamases. The accumulation of CAZ* and CAZ** were determined by microspectrofluorimetry and epifluorimetry. The derivatives were properly translocated to the periplasmic space when we permeabilize the outer membrane barrier. The periplasmic location of CAZ** was related to a significant antibacterial activity and with the outer membrane permeability. This study demonstrated the correlation between periplasmic accumulation and antibiotic activity. We also validated the method for approaching ß-lactam permeation relative to membrane permeability and paved the way for an original matrix for determining “Structure Intracellular Accumulation Activity Relationship” for the development of new therapeutic candidates.Anas AllamLaure MaigreJulia VergalliEstelle DumontBertrand CinquinRodolphe Alves de SousaJelena PajovicElizabeth PinetNikaia SmithJean-Philippe HerbeuvalMatthieu RéfrégiersIsabelle ArtaudJean-Marie PagèsNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Anas Allam
Laure Maigre
Julia Vergalli
Estelle Dumont
Bertrand Cinquin
Rodolphe Alves de Sousa
Jelena Pajovic
Elizabeth Pinet
Nikaia Smith
Jean-Philippe Herbeuval
Matthieu Réfrégiers
Isabelle Artaud
Jean-Marie Pagès
Microspectrofluorimetry to dissect the permeation of ceftazidime in Gram-negative bacteria
description Abstract A main challenge in chemotherapy is to determine the in cellulo parameters modulating the drug concentration required for therapeutic action. It is absolutely urgent to understand membrane permeation and intracellular concentration of antibiotics in clinical isolates: passing the membrane barrier to reach the threshold concentration inside the bacterial periplasm or cytoplasm is the pivotal step of antibacterial activity. Ceftazidime (CAZ) is a key molecule of the combination therapy for treating resistant bacteria. We designed and synthesized different fluorescent CAZ derivatives (CAZ*, CAZ**) to dissect the early step of translocation-accumulation across bacterial membrane. Their activities were determined on E. coli strains and on selected clinical isolates overexpressing ß-lactamases. The accumulation of CAZ* and CAZ** were determined by microspectrofluorimetry and epifluorimetry. The derivatives were properly translocated to the periplasmic space when we permeabilize the outer membrane barrier. The periplasmic location of CAZ** was related to a significant antibacterial activity and with the outer membrane permeability. This study demonstrated the correlation between periplasmic accumulation and antibiotic activity. We also validated the method for approaching ß-lactam permeation relative to membrane permeability and paved the way for an original matrix for determining “Structure Intracellular Accumulation Activity Relationship” for the development of new therapeutic candidates.
format article
author Anas Allam
Laure Maigre
Julia Vergalli
Estelle Dumont
Bertrand Cinquin
Rodolphe Alves de Sousa
Jelena Pajovic
Elizabeth Pinet
Nikaia Smith
Jean-Philippe Herbeuval
Matthieu Réfrégiers
Isabelle Artaud
Jean-Marie Pagès
author_facet Anas Allam
Laure Maigre
Julia Vergalli
Estelle Dumont
Bertrand Cinquin
Rodolphe Alves de Sousa
Jelena Pajovic
Elizabeth Pinet
Nikaia Smith
Jean-Philippe Herbeuval
Matthieu Réfrégiers
Isabelle Artaud
Jean-Marie Pagès
author_sort Anas Allam
title Microspectrofluorimetry to dissect the permeation of ceftazidime in Gram-negative bacteria
title_short Microspectrofluorimetry to dissect the permeation of ceftazidime in Gram-negative bacteria
title_full Microspectrofluorimetry to dissect the permeation of ceftazidime in Gram-negative bacteria
title_fullStr Microspectrofluorimetry to dissect the permeation of ceftazidime in Gram-negative bacteria
title_full_unstemmed Microspectrofluorimetry to dissect the permeation of ceftazidime in Gram-negative bacteria
title_sort microspectrofluorimetry to dissect the permeation of ceftazidime in gram-negative bacteria
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/ca80691df79d435fac589a85f21b0920
work_keys_str_mv AT anasallam microspectrofluorimetrytodissectthepermeationofceftazidimeingramnegativebacteria
AT lauremaigre microspectrofluorimetrytodissectthepermeationofceftazidimeingramnegativebacteria
AT juliavergalli microspectrofluorimetrytodissectthepermeationofceftazidimeingramnegativebacteria
AT estelledumont microspectrofluorimetrytodissectthepermeationofceftazidimeingramnegativebacteria
AT bertrandcinquin microspectrofluorimetrytodissectthepermeationofceftazidimeingramnegativebacteria
AT rodolphealvesdesousa microspectrofluorimetrytodissectthepermeationofceftazidimeingramnegativebacteria
AT jelenapajovic microspectrofluorimetrytodissectthepermeationofceftazidimeingramnegativebacteria
AT elizabethpinet microspectrofluorimetrytodissectthepermeationofceftazidimeingramnegativebacteria
AT nikaiasmith microspectrofluorimetrytodissectthepermeationofceftazidimeingramnegativebacteria
AT jeanphilippeherbeuval microspectrofluorimetrytodissectthepermeationofceftazidimeingramnegativebacteria
AT matthieurefregiers microspectrofluorimetrytodissectthepermeationofceftazidimeingramnegativebacteria
AT isabelleartaud microspectrofluorimetrytodissectthepermeationofceftazidimeingramnegativebacteria
AT jeanmariepages microspectrofluorimetrytodissectthepermeationofceftazidimeingramnegativebacteria
_version_ 1718384621112000512